Company Brighten Optix Corporation

Equities

6747

TW0006747009

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Quarterly revenue - Rate of surprise

Sector Glasses, Spectacles & Contact Lenses

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
182 ^TWD	+1.11%		+2.54%	-3.96%

Mar. 15	Brighten Optix Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Brighten Optix Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

BRIGHTEN OPTIX CORPORATION is a Taiwan-based company principally engaged in the manufacture and sale of contact lenses. The Company is engaged in the manufacture of custom-made hard contact lenses, custom-made soft contact lenses, as well as the agency, distribution and sale of contact lens care products. The custom-made hard contact lenses include Rigid Gas-Permeable Lens and Orthokeratology Lenses. The Company distributes its products mainly in China.

TWD in Million	2022	Weight	2023	Weight	Delta
Hard and Soft Contact Lenses 96.9 %	723	97.2 %	724	96.9 %	+0.10%
Authorized Income 2.0 %	16	2.1 %	15	2.0 %	-7.29%
Other 1.2 %	5	0.7 %	9	1.2 %	+67.43%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 52.2 %	338	45.4 %	390	52.2 %	+15.47%
China 45.7 %	393	52.8 %	342	45.7 %	-13.12%
Others 2.1 %	14	1.8 %	16	2.1 %	+17.49%

Managers	Title	Age	Since
Tai Hsiung Wu CEO	Chief Executive Officer	-	76-04-30
Chu Yin Yeh DFI	Director of Finance/CFO	-	-
Yi Tsung Wu CTO	Chief Tech/Sci/R&D Officer	-	15-01-27
Kuan Han Wu BRD	Director/Board Member	-	15-12-31
Yi Yeh PRN	Corporate Officer/Principal	-	16-01-24

Members of the board	Title	Age	Since
Shih Fang Chiu BRD	Director/Board Member	-	19-09-19
Che Yu Li BRD	Director/Board Member	-	19-09-19
Tai Hsiung Wu CEO	Chief Executive Officer	-	76-04-30
Yi Tsung Wu CTO	Chief Tech/Sci/R&D Officer	-	15-01-27
Kuan Han Wu BRD	Director/Board Member	-	15-12-31
Chih Yuan Yu BRD	Director/Board Member	-	19-09-19
Mei Chuan Tai BRD	Director/Board Member	-	19-09-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,189,000	8,083,000 ( 33.42 %)	0	33.42 %

Name	Equities	%	Valuation
AHAM Asset Management Bhd. 0.6201 %	150,000	0.6201 %	878 810 NT$
DFA Australia Ltd. 0.001253 %	303	0.001253 %	1 775 NT$

Brighten Optix Corp.

6/F-1 150 & 152, Section 4, Chengde Road

111 51, Taipei

http://www.brightenoptix.com.tw

address Brighten Optix Corporation(6747)

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

40.79 CNY

Average target price

51.43 CNY

Spread / Average Target

+26.06%

Consensus

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
BRIGHTEN OPTIX CORPORATION	-3.96%	136M
ESSILORLUXOTTICA	+11.23%	98.38B
ALCON INC.	+9.93%	39.34B
THE COOPER COMPANIES, INC.	-4.20%	18.02B
AUTEK CHINA INC.	-16.61%	2.33B
WARBY PARKER INC.	-10.04%	1.51B
PEGAVISION CORPORATION	+26.36%	1.21B
MINGYUE OPTICAL LENS CO.,LTD.	-34.97%	755M
MENICON CO., LTD.	-36.42%	744M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-8.48%	665M

Glasses, Spectacles & Contact Lenses